WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

PEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma/High-grade Glioma and Recurrent Diffuse Midline Glioma/High-grade Glioma, Medulloblastoma, and Ependymoma

Phase 1

Not yet recruiting

Conditions: Diffuse Midline Glioma
Diffuse Midline High-grade Glioma
Medulloblastoma
Ependymoma

Interventions: Biological: PEP-CMV vaccine
Biological: Tetanus booster
Biological: Nivolumab
Drug: Temozolomide

First Posted Date: 2024-10-14

Last Posted Date: 2024-10-14

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 68

Registration Number: NCT06639607

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States

Language Matters: Exploring the Impact of Language Concordance on Fertility Treatment Progression

Not Applicable

Not yet recruiting

Conditions: Infertility
Infertility (IVF Patients)
Infertility Assisted Reproductive Technology
Ovulation Ind

First Posted Date: 2024-10-11

Last Posted Date: 2024-10-11

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 70

Registration Number: NCT06636838

Locations: 🇺🇸
Washington University in St Louis, Saint Louis, Missouri, United States

Window of Opportunity Study of DSP-0390 in Gliomas

Early Phase 1

Not yet recruiting

Conditions: Glioma, Malignant
Grade II Glioma
IDH Mutation

Interventions: Drug: DSP-0390

First Posted Date: 2024-10-10

Last Posted Date: 2024-10-10

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 20

Registration Number: NCT06636162

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Maternal Maneuvers During Prolonged Labor

Not Applicable

Recruiting

Conditions: Labor Stage, First
Prolonged Labor

Interventions: Other: Circuit of maternal position changes during labor

First Posted Date: 2024-10-10

Last Posted Date: 2024-12-16

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 82

Registration Number: NCT06636149

Locations: 🇺🇸
Washington University Medicine, Saint Louis, Missouri, United States

64Cu-LLP2A for Imaging Hematologic Malignancies

Early Phase 1

Not yet recruiting

Conditions: Multiple Myeloma
Low-Grade Lymphoma
Follicular Lymphoma
Marginal Zone Lymphoma
Lymphoplasmacytic Lymphoma
Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia

Interventions: Drug: 64Cu-LLP2A
Device: PET/CT

First Posted Date: 2024-10-10

Last Posted Date: 2024-10-10

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 42

Registration Number: NCT06636175

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Lymphodepleting Total Body Irradiation (TBI) Plus Cyclophosphamide Prior to Ciltacabtagene Autoleucel (Carvykti; Cilta-cel) for Multiple Myeloma (MM) Patients With Impaired Renal Function

Phase 1

Recruiting

Conditions: Multiple Myeloma

Interventions: Drug: Cyclophosphamide
Drug: Ciltacabtagene Autoleucel
Radiation: Total body irradiation

First Posted Date: 2024-10-02

Last Posted Date: 2024-12-18

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 12

Registration Number: NCT06623630

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Improving Cancer Prevention and Control Through Academic-local Public Health Department Partnerships

Not Applicable

Not yet recruiting

Conditions: Cancer

Interventions: Behavioral: Resources and guided facilitation
Behavioral: Existing resources

First Posted Date: 2024-09-20

Last Posted Date: 2024-09-20

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 364

Registration Number: NCT06605196

Locations: 🇺🇸
Prevention Research Center at Washington University in St. Louis, St. Louis, Missouri, United States

Mental and Cognitive Health and Physical Activity in the Perioperative Breast Cancer Setting

Completed

Conditions: Breast Cancer
Breast Neoplasms
Cancer, Breast
Cancer of the Breast

Interventions: Other: Actigraph
Other: Questionnaires
Other: BrainBaseline application
Other: Semi-structured interviews

First Posted Date: 2024-09-16

Last Posted Date: 2024-09-16

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 42

Registration Number: NCT06595901

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Smoldering Inflammation in MS

Recruiting

Conditions: Multiple Sclerosis

First Posted Date: 2024-09-11

Last Posted Date: 2024-09-11

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 25

Registration Number: NCT06591429

Enhanced Assistance During Radiotherapy for Unmet Essential Needs

Not Applicable

Recruiting

Conditions: Bone Cancer
Brain Cancer
Colorectal Cancer
Esophagus Cancer
Lymphoma
Salivary Gland Cancer
Head and Neck Cancer
Liver Cancer
Ovarian Cancer
Pancreatic Cancer

Interventions: Other: Standard assistance
Other: Enhanced assistance

First Posted Date: 2024-09-03

Last Posted Date: 2024-10-08

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 33

Registration Number: NCT06582849

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy